top of page
The Nørregaard Lab
Open Discovery Innovation Network (ODIN)
In the FRIGG project, part of the Open Discovery Innovation Network (ODIN) and headed by Lene Niemann Nejsum & Rikke Nørregaard, we will use fresh human kidney tissue to model the early stages of chronic kidney disease in order to identify new biomarkers and therapeutic targets, in collaboration with industry partners from AstraZeneca, Nordic Bioscience and Novo Nordisk.
You can read more about FRIGG and ODIN here
For more information about the FRIGG project please contact Rikke Nørregaard or Rick Mutsaers.
bottom of page